Anderson Karen M.
Chief People Officer
Anderson Karen M. has filed 6 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Jun 24, 2026.
On the most recent filing, Anderson Karen M. is listed as Chief People Officer at Centessa Pharmaceuticals plc. Inside the rolling window, Anderson Karen M. reported no open-market purchases and 4 open-market sales totaling $6.5M in CNTA. The largest disclosed transaction in the window is a sale of 120,029 CNTA shares on Mar 13, 2026, worth $3.2M.
Companies traded
Other insiders at CNTA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$6.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Anderson Karen M. made?
Anderson Karen M. has filed 6 SEC Form 4 filings (16 transaction rows) across 1 company since 2026.
Which companies does Anderson Karen M. trade?
Anderson Karen M. has filed SEC Form 4 disclosures for 1 company, including CNTA.
When was Anderson Karen M.'s most recent SEC Form 4 filing?
Anderson Karen M.'s most recent SEC Form 4 filing on Tracefour is dated Jun 24, 2026.
What is Anderson Karen M.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Anderson Karen M. is listed as Chief People Officer.
What is Anderson Karen M.'s total buy and sell value in the current window?
Inside the rolling retention window, Anderson Karen M. bought $0 and sold $6.5M based on SEC Form 4 filings.
What was Anderson Karen M.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 120,029 CNTA shares on 2026-03-13, worth $3.2M, per SEC Form 4 filings.